#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immune-mediated renal disorder T-cell type acute leukaemia Neonatal alloimmune thrombocytopenia Allogenic stem cell transplantation Hereditary neuropathic amyloidosis Univentricular heart CDKL5 deficiency disorder Stevens-Johnson syndrome Malignant melanoma Behcet's syndrome Blood iron increased Hyperadrenocorticism Mastocytosis Acute graft versus host disease in liver Chronic cutaneous lupus erythematosus More trials…

    Learn about Rare Diseases

    Crigler-Najjar syndrome – Diagnostics Optic glioma Prader-Willi syndrome Thrombotic thrombocytopenic purpura – Life with Disease Encephalitis autoimmune – Life with Disease Burkitt’s lymphoma – Treatment Leiomyosarcoma – Trials in Disease Lymphatic malformation Gaucher’s disease type III Propionic acidaemia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Follitropin Alfa AZD0022 Teropavimab Golexanolone Dobutamine Mercaptopurine Dl-Alpha-Tocopherol Imetelstat Sodium Envudeucitinib Anhydrous Cyclophosphamide Abc-23A-116 Inclisiran Sodium Flutemetamol (18F) Disulfiram Isoleucine Setmelanotide Sitagliptin POTASSIUM CLAVULANATE Bi 3032950 SIPAVIBART More therapies…

    Learn about Your Condition

    Synovial sarcoma Pulmonary congestion Hypertrophic cardiomyopathy Limb reduction defect Rhabdoid tumour of the kidney Diabetic foot Microvillous inclusion disease Low cardiac output syndrome Macular degeneration Nodular melanoma HER2 positive breast cancer Pancreatic fistula Circulatory collapse Nasopharyngeal cancer Choreoathetosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effectiveness of Bevacizumab and Drug Combination for Children with Recurrent or Progressive Medulloblastoma, Ependymoma, and ATRT

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Medulloblastoma
    Investigated Drugs:
    • Thalidomide
    • Fenofibrate
    • Celecoxib
    Austria Czechia Denmark France Norway Spain +1

  • Study on the Effectiveness of Atenativ for Patients with Congenital Antithrombin Deficiency Undergoing Surgery or Childbirth

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Antithrombin III deficiency
    Investigated Drugs:
    • Antithrombin Iii Human
    • Human Plasma Derived Antithrombin
    Austria Czechia France Germany Hungary Italy +2

  • Study of Taletrectinib for Patients with Advanced or Metastatic ROS1 Positive Non-Small Cell Lung Cancer

    Recruiting

    2 1 1
    Investigated Drugs:
    • Taletrectinib
    France Italy Poland Spain

  • Study on Short vs. Long Immunotherapy with Pembrolizumab and Nivolumab for Patients with High-Risk Skin Melanoma After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Nivolumab
    • Pembrolizumab
    Finland Norway Sweden

  • Study on Dapagliflozin and Lifestyle Changes for Patients with Early Chronic Kidney Disease and Prediabetes

    Recruiting

    3 1 1
    Investigated Drugs:
    • Dapagliflozin
    Germany

  • Study on ONC201 and Everolimus with Radiotherapy for Newly Diagnosed Diffuse Intrinsic Pontine Glioma and Other Diffuse Midline Gliomas in Children, Adolescents, and Adults

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Brain stem glioma
    Investigated Drugs:
    • 2,4,6,7,8,9-Hexahydro-4-((2-Methylphenyl)Methyl)-7-(Phenylmethyl)Imidazo(1,2-A)Pyrido(3,4-E)Pyrimidin-5(1H)-One
    • Everolimus
    Belgium Denmark Finland France Greece Norway +2
Previous Page
1 … 607 608 609 610 611 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!